- Report
- May 2026
- 150 Pages
Mexico
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
China
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
Spain
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
Turkey
From €4463EUR$4,850USD£3,727GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4463EUR$4,850USD£3,727GBP
- Report
- April 2025
- 150 Pages
Global
From €4463EUR$4,850USD£3,727GBP
- Report
- March 2025
- 150 Pages
Global
From €4463EUR$4,850USD£3,727GBP
- Report
- March 2025
- 150 Pages
Global
From €4463EUR$4,850USD£3,727GBP
- Report
- September 2024
- 150 Pages
Global
From €4463EUR$4,850USD£3,727GBP
- Report
- November 2025
- 60 Pages
United States
From €2346EUR$2,550USD£1,960GBP
- Report
- November 2025
- 60 Pages
United States
From €2346EUR$2,550USD£1,960GBP
- Report
- November 2025
- 110 Pages
North America
From €2990EUR$3,250USD£2,498GBP
- Report
- November 2025
- 140 Pages
Europe
From €2990EUR$3,250USD£2,498GBP
- Report
- October 2025
- 90 Pages
North America
From €2990EUR$3,250USD£2,498GBP
- Report
- October 2025
- 160 Pages
Global
From €4463EUR$4,850USD£3,727GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more